ArticleEvidence-based medicine2016

Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment.

George W Rutherford et al.PubMed ↗Publisher ↗

No numbers read from the abstract.